ClinicalTrials.gg

Moderna, Inc. clinical trials

Also known as Moderna Therapeutics.

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 119 studies whose lead sponsor is Moderna, Inc. or one of 1 company grouped under it. 18 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 13, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Moderna with Sanofi and Hoffmann-La Roche →

Pipeline: 16 programs

Each counted once: 16 with a study Moderna, Inc. leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 3 phase-3 programs — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Moderna, Inc.’s own registered studies; Moderna, Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

One of Moderna’s programs has a dated deal behind it: 1 developed with a partner. Each from the companies’ own releases and filings, linked; the registry does not record them.

Developed with a partner 1

What it is testing

The drugs Moderna, Inc.’s studies test, most open studies first — 10 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

16 of Moderna, Inc.’s studies under way reach primary completion within a year, 2 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. 4D
  3. 1J’27
  4. 1F
  5. 1M
  6. A
  7. 1M
  8. 1J
  9. 1J
  10. 2A
  11. 1S
  12. 1O
  13. 1N

The 12 nearest

Show 7 more

Add all 16 to your calendar (.ics) → With an account.

All 119 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1815%Recruiting 16 · Not yet recruiting 2
  • Under way, not recruiting1311%
  • Completed7866%
  • Stopped early108%Terminated 6 · Withdrawn 4

Phase

  • Phase 153
  • Phase 245
  • Phase 323
  • Phase 46

Where

  • United States95
  • United Kingdom28
  • Canada21
  • Australia17
  • Japan14
  • Spain12

Over the years

  1. 15
  2. 16
  3. 17
  4. 18
  5. 19
  6. 20
  7. 21
  8. 22
  9. 2623
  10. 24
  11. 25
  12. 1126

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Moderna, Inc..

  • ModernaTX, Inc.
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    119 studies →

Focus areas

Conditions Moderna, Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 119. Browse all 119 →